Clinical Trials Registration Efforts Gain Some Ground

Zielinski, Sarah L.
March 2005
JNCI: Journal of the National Cancer Institute;3/16/2005, Vol. 97 Issue 6, p410
Academic Journal
Reports on the progress in clinical trials registration efforts in the U.S. Support of the pharmaceutical industry to several principles of clinical trials registration; Efforts of the World Health Organization to standardize information collected in clinical trial registries.


Related Articles

  • Phase III Failures: What Can Be Done? Beltangady, Mohan // Applied Clinical Trials;Sep2005, Vol. 14 Issue 9, p82 

    Looks at what can be done to prevent failures in Phase III clinical trials. Increasing costs of drug development; Possible reasons for why Phase III trials may fail to confirm what has been learned from Phase II studies; Value of flexible trial designs.

  • How Do Pharmaceutical Companies Approach Data from Sexual Health Studies for Regulatory Agencies? Dilleen, Maria; Haughie, Scott // Annual Review of Sex Research;2005, Vol. 16 Issue 1, p53 

    The article outlines the importance of statistical input into clinical trial research in the pharmaceutical industry an in interactions with regulatory agencies. It focuses on the role of statisticians in projects on sexual health during the 2nd and 3rd phases of clinical trials that are...

  • Randomized clinical trials: Slow death by a thousand unnecessary policies? Ferris, Lorraine E.; Naylor, C. David // CMAJ: Canadian Medical Association Journal;10/12/2004, Vol. 171 Issue 8, p892 

    Focuses on financial conflicts of interest between researchers and industry sponsors in conducting clinical trials. Roles of researchers in clinical trials; Purpose of pharmaceutical companies in conducting their own clinical trials; Susceptibility of preapproval studies by pharmaceutical...

  • Engaging Tomorrow's Volunteers Through Museum Learning. Getz, Kenneth A. // Applied Clinical Trials;Jun/Jul2014, Vol. 23 Issue 6/7, p18 

    The article discusses the efforts to provide outreach and education to inform patients and the public about the clinical research process. The author reveals that the National and international polls conducted by the Center for Information and Study on Clinical Research Participation (CISCRP)...

  • PER-PATIENT COSTS CLIMB THROUGH CLINICAL TRIAL.  // Biotech Business;May2013, Vol. 26 Issue 5, p6 

    The article discusses a study on the correlation between patient enrollment and total cost as depicted in the Cutting Edge Information study. It provides an overview of the study involving the phase 1, 2 and 3 of the clinical trials and its average total cost. It also highlights the latest...

  • Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies. Revicki, D.A.; Frank, L. // PharmacoEconomics;1999, Vol. 15 Issue 5, p423 

    Pharmacoeconomic data may be obtained within the context of randomised clinical trials (RCTs) and from effectiveness studies in the 'real world'. The differences between the 2 types of study design have implications for the types of data that can be obtained and the interpretation of the...

  • Evaluating solutions to sponsorship bias. Doucet, M.; Sismondo, S. // Journal of Medical Ethics;Aug2008, Vol. 34 Issue 8, p627 

    More than 40 primary studies, and three recent systematic reviews and meta-analyses, have shown a clear association between pharmaceutical industry funding of clinical trials and pro-industry results. Industry sponsorship biases published scientific research in favour of the sponsors, a result...

  • From Study Initiation to Publication-- The Role of Clinical Trial Registers. Rockhold, Frank.; Freeman, Andrew; Metz, Craig; Merchant, Tom; Fuell, Diane; Gallacher, Tom; Krall, Ron // Applied Clinical Trials;Sep2005, Vol. 14 Issue 9, p38 

    Summarizes the historical development of clinical trial registers and assesses the progress that has been made in the area of providing a continuum of clinical trial information, from trial initiation to publication of results. Description of the two types of clinical trial registers; Examples...

  • Clinical Trials Research in Pediatrics: Strategies for Effective Collaboration Between Investigator Sites and the Pharmaceutical Industry. Bush, Andrew // Pediatric Drugs;2006, Vol. 8 Issue 5, p271 

    There is a paucity of clinical trials work in children, which leads to the frequent use of off-label and unlicensed medications in this very vulnerable group. Clinical trials work in children may be more difficult than in adults, and there are certainly ethical constraints. However, the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics